Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Viracta Therapeutics Inc.
Sponsor

Viracta Therapeutics Inc.

United States 2533 South Coast Highway 101 Suite 210, 92007-2133, United States

About the sponsor

Viracta Therapeutics Inc. focuses on advanced cancer and relapsed/refractory lymphomas, with particular interest in solid and hematologic malignancies that remain difficult to treat.

  • Advanced cancer
  • Relapsed/refractory lymphoma
  • Epstein-Barr virus-positive malignancy

The company’s research activity centers on cancers with limited treatment options, including disease settings marked by recurrence and resistance to prior therapy.

About Specializations

Viracta Therapeutics Inc. runs clinical trials in conditions such as Epstein-Barr virus associated lymphoma, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Epstein-Barr virus associated lymphoma

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ganciclovir Sodium
  • Sponsor:Viracta Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.